• A Discussion with Brian Finn of Findell Capital: Biotech Investing, Liquidia & ProQR

  • Nov 30 2021
  • Length: 49 mins
  • Podcast

A Discussion with Brian Finn of Findell Capital: Biotech Investing, Liquidia & ProQR

Listen for free

View show details

  • Summary

  • An interview with Brian Finn of Findell Capital, where we discuss his perspective on small-cap investing. During the interview, we discuss two of Brian's favorite health care names, Liquidia and ProQR, as well as his previous success with MiMedx. To learn more about Findell Capital please visit their website https://findell.us/

    Companies discussed during the podcast;

    • Liquidia Corporation (Nasdaq: LQDA)
    • ProQR Therapeutics N.V. (Nasdaq: PRQR)
    • MiMedx Group Inc (Nasdaq: MDXG)
    • United Therapeutics Corporation (Nasdaq: UTHR)
    • MannKind Corporation (Nasdaq: MNKD)
    • Editas Medicine Inc (Nasdaq: EDIT)
    Show More Show Less
Show More Show Less

What listeners say about A Discussion with Brian Finn of Findell Capital: Biotech Investing, Liquidia & ProQR

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available